SB 387 — HEALTH/ACC INSURANCE: Provides relative to pharmacy benefit managers. (1/1/27) (EN INCREASE SG EX See Note)
Last action — Signed by the Governor. Becomes Act No. 914.
-
✓Introduced
-
✓In Committee
-
✓Passed Senate
-
✓Passed House
-
✓To Executive
-
6Enacted
This bill has been enacted into law. Introduced February 27, 2026. Enacted.
Signed by Governor Jeff Landry (Republican) on June 12, 2026.
Odds of enactment
High chanceBased on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
-
Enacted
Current position in the legislative process.
-
3 sponsors
1 primary, 2 co-sponsors signed on.
-
Single-party support
Sponsorship is currently within one party (3 R).
-
Cleared a recorded vote
Passed 5 recorded votes so far.
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
In plain language
The bill regulates pharmacy benefit managers in health insurance.
This legislation outlines new regulations for pharmacy benefit managers, aiming to impact how medications are managed within health insurance plans. It addresses the role and responsibilities of these managers in the healthcare system.
What this means for you
- Consumers: Consumers may see changes in how their medications are managed and potentially improve access to affordable drugs.
- Healthcare: This means that healthcare providers will have more structured guidelines to follow when working with pharmacy benefit managers.
Bill Text
What changed in the latest version
586 added · 558 removedPlain-language change summary
The changes to SB 387 include the addition of new sections that establish stronger regulations for pharmacy benefit managers, including guidelines on audits, appeals, and compensation related to pharmacy practices. Notably, the revised bill ensures that audits on a pharmacy's records cannot occur more than once a year and are limited to claims submitted within the past year. These adjustments are crucial as they aim to protect pharmacies from excessive scrutiny and enhance transparency, ultimately benefiting patients by ensuring better management of their health plans.
SLS 26RS-518 REENGROSSED Regular Session ENROLLED SENATE BILL NO.
387 BY SENATORS BASS AND TALBOT HEALTH/ACCAND INSURANCE.REPRESENTATIVE TURNER AN ACT To amend and reenact R.S.
Provides22:1856.1(B)(2)(a), relative1863, to1865(A), pharmacyand benefitthe managers.introductory paragraph of 1865(G), R.S.
(1/1/27)39:1600.1(A), ANthe ACTintroductoryparagraphof To1600.1(D), amendand 1600.1(D)(6), and reenactR.S.R.S.
22:1856.1(B)(2)(a),1863, and 1865(A) and R.S.
22:1868.1,22:1868.1 and Section 5 of Act 474 of the 2025 Regular Session, relative to pharmacypharmacybenefit benefit managers;
to provide for the costs of implementation and enforcement;
to provide for data sharing;
22:1856.1(B)(2)(a), 1863, 1865(A), and 1865(A)the introductory paragraph of 1865(G) are hereby amended and reenacted and R.S.
22:1867.1 and 1868.2 are herebyenactedhereby enacted to read as follows:
Page* 1* of* 18(2)(a)Noentityshallconductanauditataparticularpharmacymorethanone Coding:time annually.
The audit shall be limited to claims submitted not more than twelve months prior to date the audit begins.
However, the provisions of this Paragraph shall not apply when an entity must return to a pharmacyto complete an audit already in progress, or there is an identified history of errors, an identified Page 1 of 19 Coding:
SLS 26RS-518 REENGROSSED SB NO.
387 *ENROLLED *activitywhichareasonablemanpersonwouldbelievetobeinappropriate,orillegal *activity (2)(a)Noentityshallconductanauditataparticularpharmacymorethanonethat timethe annually.entity has brought to the attention of the pharmacy owner or corporate headquarters of the pharmacy.
The audit shall be limited to claims submitted not more than twelve months prior to date the audit begins.
However, the provisions of this Paragraph shall not apply when an entity must return to a pharmacyto complete an audit already in progress, or there is an identified history of errors, an identified activitywhichareasonablemanpersonwouldbelieveto beinappropriate,orillegal activity that the entity has brought to the attention of the pharmacy owner or corporate headquarters of the pharmacy.
(3) "Enrollee" means any individual entitled to coverage of healthcare services fromunder athe healthterms insuranceof issuer under a health benefit plan.
(3)(4) "Health benefit plan", "health plan", "plan", "benefit", or "health insurance coverage" means services consisting of medical care provided directly throughinsurance,reimbursement,orothermeans,andincludingitemsandservices paid for as medical care under anyanyhospital hospital or medical service policypolicyor or certificate, hospital or medical service plan contract, preferred provider organization contract, or health maintenance organization contract offered by a health insurance issuer.
(5) "Healthcare service" means an item or service furnished to any individual for the purpose of preventing, diagnosing, alleviating, curing, or Pagehealing 2human ofillness, 18injury, Coding:or physical disability.
Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.
SLS 26RS-518 REENGROSSED SB NO.
387 healing human illness, injury, or physical disability.
(5)(7)"Localpharmacy"meansapharmacyasdefinedintheNorthAmerican IndustryPage Classsification2 Classificationof System19 (NAICS)Coding: Code 456110, which is domiciled in Louisiana and has fewer than ten retail outlets under its corporate umbrella.
(6)(8)"MaximumWords AllowableCostList"meansalistingoftheNationalDrug Code used by a pharmacy benefit manager setting the maximum allowable cost on which reimbursementare tostruck athrough pharmacyare ordeletions pharmacistfrom mayexisting belaw; based.
words in boldface type and underscored are additions.
SB NO.
387 ENROLLED Industry Classsification Classification System (NAICS) Code 456110, which is domiciled in Louisiana and has fewer than ten retail outlets under its corporate umbrella, or which is owned and operated by a nonprofit health system, or any affiliated hospital, domiciled in Louisiana.
(6)(8)"MaximumAllowableCostList"meansalistingoftheNationalDrug Code used by a pharmacy benefit manager setting the maximum allowable cost on which reimbursement to a pharmacy or pharmacist may be based.
(14) "Pharmacy benefit management fee" means a fee that covers the costofcost of providing one or more pharmacy benefitbenefitmanagementservicesand managementthat servicesanddoes thatnot Pageexceed 3the value of 18the Coding:service or services actually performed by the pharmacy benefit manager.
(15) "Pharmacy benefit management service" means any of the following:
(a)Negotiatingthepriceofprescriptiondrugs,includingnegotiatingand contractingfordirectorindirectrebates,discounts, orotherpriceconcessions.
(b)Managinganyaspectofaprescriptiondrugbenefitincludingbutnot Page 3 of 19 Coding:
SLS 26RS-518 REENGROSSED SB NO.
387 doesENROLLED notlimited exceedto the valueprocessing and payment of claims for prescription drugs, the serviceperformance of drug utilization review, the processing of drug prior authorization requests,theadjudication of appeals or servicesgrievances actuallyrelatedtothe performedprescriptiondrugbenefit,contractingwithnetworkpharmacies,controllingthe bycost of covered prescription drugs, managing or providing data relating to the pharmacyprescription benefitdrug manager.benefit, or the provision of services related thereto.
(15) "Pharmacy benefit management service" means any of the following:
(a)Negotiatingthepriceofprescriptiondrugs,includingnegotiatingand contractingfordirectorindirectrebates,discounts,orotherpriceconcessions.
(b)Managinganyaspectofaprescriptiondrugbenefitincludingbutnot limited to the processing and payment of claims for prescription drugs, the performance of drug utilization review, the processing of drug prior authorization requests, the adjudication of appeals orgrievancesrelatedto the prescriptiondrugbenefit,contractingwithnetworkpharmacies,controllingthe cost of covered prescription drugs, managing or providing data relating to the prescription drug benefit, or the provision of services related thereto.
22:1641 and includes any person, either directly or indirectly, that provides one or more pharmacy benefit management services on behalf of an insurer or health plan, and anyagent, contractor,intermediary, affiliate, subsidiary, or related entity of such person who facilitates, provides, directs, or overseesoverseesthe the provision ofthe pharmacybenefit management servicesor entity, and any subsidiary, parent, or affiliate of thesuch pharmacybenefitentity that directly or indirectly facilitates,provides,directs,manages,administers,oroverseestheprovisionof one or more pharmacy benefit management services.
Show all 272 changed lines (232 more)
The administration or management of a prescription benefits plan includes direct or indirect participation at any stage in the negotiation or determination of prescription drugpricingultimatelyassessedtoaninsurer'sorpharmacybenefitmanager's client health benefit plan.
(13)(19)"Rebates"meanseitherofthefollowing:allrebates,discounts,and other price concessions, based on utilization of a prescription drug and paid by the Page 4 of 1819 Coding:
SLS 26RS-518 REENGROSSED SB NO.
387 otherENROLLED price concessions, based on utilization of a prescription drug and paid by the manufacturer or other party other than an enrollee, directly or indirectly, to the pharmacy benefit manager after the claim has been adjudicated at the pharmacy.
(a) NegotiatedDrug manufacturer price concessions including but not limited to base price concessions, whether described as a rebate or otherwise, and reasonable estimates of any price protection rebates and performance-based price concessionsthatmayaccruedirectlyorindirectlytothehealthinsuranceissuerconcessions orhealththat may accruedirectlyorindirectlytothepharmacybenefitmanager,healthinsurance issuer or health plan, orotherpartyonor other party on behalf of the health insurance issuer orhealthor health plan, including a pharmacy benefit manager, during the coverage year from a manufacturer, dispensing pharmacy, or other party in connection with the dispensing or administration of a prescription drug.
(b) Reasonable estimates of any negotiated price concessions, fees, and other administrative costs that are passed through, or are reasonably anticipated to be passed through, to the health insurance issuer or health plan and serve to reduce the health insurance issuer or health plan's liabilities for a prescription drug.
(ii) A person or entity that is treated under the rules as affiliated with a Pagepharmacy 5benefit ofmanager 18in Coding:cases where the pharmacy benefit manager is a person other than a corporation.
Page 5 of 19 Coding:
SLS 26RS-518 REENGROSSED SB NO.
387 pharmacyENROLLED benefit(14)(21) manager"Specialty indrug" casesmeans wherea thedrug pharmacythat benefitmeets managerall isof athe personfollowing othercriteria: than a corporation.
(14)(21) "Specialty drug" means a drug that meets all of the following criteria:
(23) "Net acquisition cost" means the amount paid to acquire a prescription drug after deducting all rebates, price concessions, fee payments, and any otherpaymentsoreconomic benefits receiveddirectly or indirectly by the pharmacy benefit manager or any related entity in connection with the selection,placement,ordispensingofthatdrug,calculatedfromtheperspective of the health benefit plan and not the pharmacy benefit manager.
maximum allowable costs A.(1) The pharmacy benefit manager shall provide a reasonable administrative appeal procedure to allow pharmacies to challenge maximum allowable costs for a specificNDC or NDCs as not meetingthe requirementsof this SubpartorbeingbelowthecostatwhichthepharmacymayobtaintheNDC.WithinSubpartorbeingbelowthecost atwhichthepharmacymayobtaintheNDC.Within fifteen business days after the applicable fill date, a pharmacymayfile an appeal by following the appeal process as provided for in this Subpart.
The pharmacybenefitpharmacy benefit managershall respondtorespondtoachallengewithin achallengewithin fifteenbusiness days afterreceiptofthe challenge.Page 6 of 19 Coding:
(2) The administrative appeal procedure shall allow a pharmacy or pharmacist the option to submit a consolidated appeal representing multiple Page 6 of 18 Coding:
SLS 26RS-518 REENGROSSED SB NO.
387 substantiallyENROLLED similarchallenge. claims.
(2) The administrative appeal procedure shall allow a pharmacy or pharmacist the option to submit a consolidated appeal representing multiple substantially similar claims.
* * * G.
The commissioner may impose a reasonable fee upon pharmacy benefit managers, in accordance with the Administrative Procedure Act, in addition to a license fee and annual report fee, in order tocover the costs of implementation and enforcementofthisSectionandR.S.22:1641through1657,1851through1864,and 1961 through 1995 any portion of this Title pertaining to pharmacy benefit management, including fees to cover the cost of all of the following:
PBM Duty (1) AAny pharmacy benefit manager shalldoing owebusiness thein pharmacythis benefitstate managershall dutyact tosolely anyfor enrollee,the health plan, or provider that receives pharmacy benefit managementof services from the pharmacyhealth benefitinsurance managerissuers orand thathealth furnishes,plans covers,for receives,which orit isprovides administeredpharmacy abenefit unitmanagement ofservices aand prescription drug for which the pharmacyenrollees benefitof managerthe hasplans. provided pharmacy benefit management services.
(a)(2)Nopharmacybenefitmanager,subsidiary,parent,oraffiliateofsuch Dutypharmacy benefit manager, either directly or indirectly, shall engage in any activity which increases the cost of prescription drugs to enrollees.health insurance issuers, health plans, or enrollees;
Therestricts pharmacyor benefitimpairs manageraccess fiduciary duty owed to enrolleesprescription shalldrugs includeexceptas dutiesdirectly ofrequired careby andthe gooddesign faithof andthe fairhealth dealing.plan;
Theor commissionerotherwise shallinterfereswiththeobligationofthepharmacybenefitmanagertoactinthebest adopt rules and regulations defining the scope of the dutiesowedtoenrollees,includingbyobligatingpharmacybenefitmanagersto provideallpharmacybenefitmanagementservicesrelatedtoformularydesign, utilization management, and grievances and appeals in a transparent manner to enrollees that is consistent with the best interest of enrolleeshealth andinsurance toissuers, disclosehealth allplans, conflictsand of interest to enrollees.
(b)(3) DutyA topharmacy healthbenefit plans.manager shall not:
The(a) pharmacyObtain benefita managerrebate,or dutyany owedother incentive or inducement including but not limited to healthdiscounts, planson shalla includename dutiesbrand drug in exchange for not placing other name brand drugs, biosimilars, generic drugs, or any other drug in the same class of caredrugs andon goodthe faithPBM andformulary, fairunless dealing.returned to the health Page 7 of 19 Coding:
The commissioner shall adopt rules and regulations defining thescopeof theduties owed to health plans, including by obligating pharmacy benefit managers to providetransparencytohealthplans aboutamountschargedorclaimedbythe pharmacybenefitmanagerinamannerthatisadequatetoidentifyallinstances of spread pricing and to disclose all conflicts of interest to health plans.
(c) Duty to providers.
The pharmacy benefit manager duty owed to providers shall include duties of care and good faith and fair dealing.
The commissioner shall adopt rulesand regulations defining the scope of the duties owed to providers, including by obligating pharmacy benefit managers to Page 7 of 18 Coding:
SLS 26RS-518 REENGROSSED SB NO.
387 provideENROLLED transparencyinsurance toissuer providers about amounts charged or claimedplan bysponsor. the pharmacybenefitmanagerinamannerthatisadequatetoidentifyallinstances of spread pricing and to disclose all conflicts of interest to providers.
(2)(b) WhereDesign therea isprescription adrug conflictformulary betweento thefavor pharmacya benefitcertain managerbranded dutiespharmaceutical owedor inbiologic accordanceover witha thistherapeutically Section,equivalent thegeneric pharmacyor benefitbiosimilar, managerunless fiduciarythe dutybranded owedpharmaceutical toor anbiologic enrolleehas shalla belower primarynet overacquisitioncostandthatlowercostisreflectedinalowerout-of-pocketexpense thefor dutyconsumers owedor tolower anypremiums otherfor party.enrollees.
(3)(c) AUse pharmacyits benefitformulary managerto shalleffectively not:ban the use of certain pharmacies by an insured.
(a)(4) ObtainNotwithstanding aany rebate,other orprovision anyof otherlaw incentiveto orthe inducementcontrary, includingupon buta notdeterminationthatapharmacybenefitmanagerhasviolatedaprovisionofthis limitedSubsection, tothe discounts,commissioner onmay impose a namefine brandin drugthe inamount exchangeof forthe notgreater placingof otherthe namecost brandto drugs,the biosimilars,health genericinsurance drugs,issuer, health plan, or anyenrollees otheror drugthe inenrichment to the samepharmacy classbenefit ofmanager drugsand onany thesubsidiaries, PBMparent, formulary.or affiliatesthereof,plusanadditionalfineoftwenty-fivethousanddollarsforeach and every act or violation, with no aggregate penalty maximum.
(b) Design a prescription drug formulary to favor a certain branded pharmaceutical or biologic over a therapeutically equivalent generic or biosimilar, unless the branded pharmaceutical or biologic has a lower net acquisitioncostandthatlowercostisreflectedinalowerout-of-pocketexpense for consumers.
(c) Charge an out-of-pocket cost share that is based on a prescription drug pricegreaterthan thepharmacybenefitmanager'snetacquisition costof the prescription drug.
(d) Use its formulary to effectivelyban the use of certain pharmacies by an insured.
(4) A person who is aggrieved by a violation of this Section may bring a civil action before a state court of competent jurisdiction against a pharmacy benefit manager.
All manufacturer rebates, whetheraccruedtoapharmacybenefitmanager,apharmacybenefitmanager's Pageaffiliated 8group ofpurchasing 18organization, Coding:or any other pharmacy benefit manager owned or affiliated entity shall be passed through to the pharmacy benefit manager's healthcare plan sponsor client as described in this Section.
(2) A pharmacy benefit manager may earn income only from the following sources:
(a) The assessment of a flat dollar service fee charged on a per-person per-month or a per-prescription or per-event basis which shall cover all of the pharmacy benefit manager's administrative, clinical, print, electronic, and related costs for the provision of prescription benefit management services to a client health benefit plan.
The flat dollar service fee may vary among a pharmacybenefitmanager'sclientsbasedonthenumberofhealthbenefitplan Page 8 of 19 Coding:
SLS 26RS-518 REENGROSSED SB NO.
387 affiliatedENROLLED groupparticipants purchasingand organization,clinical orand anyadministrative otherservicesprovided, pharmacyand benefit manager owned or affiliated entity shall be passedset throughforth toin thea pharmacywritten benefitagreement manager'sbetween healthcarethe planparties. sponsor client as described in this Section.
(2) A pharmacy benefit manager may earn income only from the following sources:
(a) The assessment of a flat dollar service fee charged on either a per- person per-month or a per-prescription basis which shall cover all of the pharmacy benefit manager's administrative, clinical, print, electronic, and related costs for the provision of prescription benefit management services to a client health benefit plan.
The flat dollar service fee may vary among a pharmacybenefitmanager'sclientsbasedonthenumberofhealthbenefitplan participants and clinical and administrative servicesprovided, and shall be set forth in a written agreement between the parties.
(4)(a) A pharmacy benefit manager shall not earn any income based directlyonprescriptiondruglistprices,acquisitioncost,averagewholesalecost, or any other metric for prescription drug pricing or fulfillment at any stage in thedrugsupply chain,including butnot limitedtoprescriptiondrugmarkups, up-charging,spreadpricingofanykind,manufacturer-derivedrevenuesofany sort, which shall include but not be limited to price protection, group purchasingpurchasingorganizationretainedrebatesorfeesofanykind,rebateaggregator organizationadministrativeoranyotherfeeschargedorcollected,couponcompensationand Pagepatientassistancecompensationfees,retaineddiscountsandrebates,andother 9manufacturer payments, and any other arrangements on price of 18prescription Coding:drugs.
(b) Any prohibited pharmacy benefitmanager income that a pharmacy manager may receive during the course of a pharmacy benefit manager's Page 9 of 19 Coding:
SLS 26RS-518 REENGROSSED SB NO.
387 shallENROLLED notoperations earn any income based directly on prescription drug list prices, acquisition cost, average wholesale cost, or any other metric for prescription drug pricing or fulfillment at any stage in theservice drug supply chain, including but not limited to prescription drug markups, up-charging, spread pricing of anyits kind,Louisiana manufacturer-derivedclient revenueshealth ofplans any sort, which shall include but not be limitedconsidered toprohibited priceincomethatthe protection,pharmacy groupbenefit purchasingmanagershall organizationpass retainedthrough rebatesin orfeesofits anyentiretytothepharmacybenefitmanager'sLouisianahealthbenefitplanclients kind, rebateaggregatoradministrative or any otherfeescharged or collected, coupon compensation and patient assistance compensation fees, retained discounts and rebates, and other manufacturer payments, and any other arrangements on pricea ofquarterly prescriptionbasis. drugs.
(b) Any prohibited pharmacy benefit managerincome that a pharmacy manager may receive during the course of a pharmacy benefit manager's operations in service of its Louisiana client health plans shall be considered prohibited income that thepharmacybenefitmanagershall pass through in its entiretytothepharmacybenefitmanager'sLouisianahealthbenefitplanclients on a quarterly basis.
This audit right is in addition to, and shall not be construed to limit, any other auditrightsauthorizedbylaworcontract.Thecommissionermayalsoexamine the books or records of any entity in a pharmacy benefit manager's corporate vertical structure, including but not limited to the insurer, group purchasing Pageorganization, 10manufacturer, ofwholesale 18distributor, Coding:special or mail order pharmacy, retail or long-term care pharmacy, and provider.
Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.
SLS 26RS-518 REENGROSSED SB NO.
387 organization, manufacturer, wholesale distributor, special or mail order pharmacy, retail or long-term care pharmacy, and provider.
(a) All reimbursementreimbursementpaid paidtoretailpharmacies,on toaclaim retailpharmacies,onlevel, aclaimlevel,forallfor all customersofthepharmacybenefitmanagerinthestate,includingdrug-specific reimbursement, dispensing fees, all rebates, other fees, ancillary charges, clawbacks, or adjustments to reimbursement.
(c)Historicalclaimsdataincludingingredientcost,quantity,dispensing fee, sales tax, usual and customary price, channel such as mail or retail, health insurancePage issuer10 orof health19 planCoding: paid amount, days' supply, the amount paid by thecoveredindividual,formularytier,acquisitioncost,andanyadministrative fee associated with the claim, as applicable.
Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.
SB NO.
387 ENROLLED insurance issuer or health plan paid amount, days' supply, the amount paid by thecoveredindividual, formularytier,acquisition cost,andanyadministrative fee associated with the claim, as applicable.
(4) The pharmacy benefit manager shall certify that all information submitted to the commissioner or any health insurance issuer or health plan in Pageaccordance 11with ofthis 18Subsection Coding:is accurate and complete in all material respects.
The certification shall be signed by the chief executiveofficer or chief financial officer of the pharmacy benefit manager.
(5)(a)The commissioner and any health insurance issuer or health plan contracted with a pharmacy benefit manager holding a license issued by the commissioner shall not directly or indirectly publish or otherwise disclose any confidential, proprietary information, including but not limited to any information that would reveal the identity of a specific health plan or manufacturer, the price charged for a specific drug or class of drugs, the amount of any rebates provided for a specific drug or class of drugs, or that wouldotherwisehavethepotentialtocompromisethefinancial,competitive,or proprietarynatureoftheinformation.Anysuchinformationshallbeprotected as confidential and proprietary information, and is not a public record and is exempt fromdisclosure pursuant tothePublicRecordsLaw,R.S.44:4.1etseq.
Page 11 of 19 Coding:
SLS 26RS-518 REENGROSSED SB NO.
387 accordanceENROLLED withThe thiscommissioner Subsection is accurate and completeany inhealth allinsurance materialissuer respects.Theor certificationhealth shallplan becontracted signedwithapharmacybenefitmanagerholding byalicenseissuedbythecommissioner theshallimposetheconfidentialityprotectionsandrequirementsofthisParagraph chiefon executiveany officeragentor ordownstreamthird chiefparty financialthat officermay ofreceiveor thehave pharmacyaccesstothis benefitinformation. manager.
(5)(b) TheNothing commissionerin andthis anyParagraph health insurance issuer or health plan contracted with a pharmacy benefit manager holding a license issued by the commissioner shall notbe directlyconstrued or indirectly publish or otherwise disclose any confidential, proprietary information, including but not limited to anyprohibit information that would reveal the identitycommissionerfromdisclosinginformationtoaPrescriptionDrugAffordability ofBoard aestablished specificpursuant healthto planthis orTitle manufacturer,if thesuch priceinformation chargedis forsubject ato specific drug or class of drugs, the amountconfidentiality ofprotections anyapplicable rebatesto provided for a specific drug or class of drugs, or that wouldotherwisehavethepotentialtocompromisethefinancial,competitive,orboard. proprietarynatureoftheinformation.Anysuchinformationshallbeprotected as confidential and proprietary information, and is not a public record and is exemptfromdisclosurepursuanttothePublic RecordsLaw,R.S.
44:4.1etseq.
The commissioner and any health insurance issuer or health plan contracted with apharmacybenefitmanagerholding alicenseissued by thecommissioner shallimposetheconfidentialityprotectionsandrequirementsofthisParagraph on any agent or downstreamthird partythatmayreceiveor have access to this information.
E.(1)Inadditiontoanyothercivilorcriminalpenaltyauthorizedbylaw,E.(1) PageIn 12addition to any other penalty authorized by law, a violation of 18this Coding:Section shall be punishable by the commissioner through a civil monetary penaltyoftwenty-fivethousanddollarsforeachandeveryactorviolation,with no aggregate penalty maximum.
Words(2) If a violation for which arethe struckcommissioner throughhas areimposed deletionsa fromfine existingin law;accordancewith this Subsection is not correctedwithin thirtydays afternotice oftheviolationisreceivedbythepharmacybenefitmanager,thecommissioner shall suspend or revoke the pharmacy benefit manager's license in accordance with R.S.
words in boldface type and underscored are additions.
SLS 26RS-518 REENGROSSED SB NO.
387 a violation of this Section shall be punishable by the commissioner through a civil monetary penalty of twenty-five thousand dollars for each and every act or violation, with no aggregate penalty maximum.
(2) If a violation for which the commissioner has imposed a fine in accordancewith this Subsection is not correctedwithin thirty days after notice oftheviolationisreceivedbythepharmacybenefitmanager,thecommissioner shall suspend or revoke the pharmacy benefit manager's license in accordance with R.S.
G.Page 12 of 19 Coding:
TheWords provisionswhich ofare thisstruck Sectionthrough shall not apply to health benefit plans that are establisheddeletions underfrom andexisting regulatedlaw; by the Employee Retirement Income Security Act (ERISA) of 1974.
words in boldface type and underscored are additions.
SB NO.
387 ENROLLED G.
The provisions of this Subpart shall apply only to the extent not preempted or otherwise prohibited by federal law.
To the extent such conflict exists,thevalidityoftheremainderofthisSubpartandtheapplicabilitythereof to any other entity, person, or circumstance shall not be affected.
H.
Pharmacy Technology and Third Party Data Sharing (1)Apharmacybenefitmanager,oranyaffiliate,subsidiary,oragentof apharmacybenefitmanager,shallnotdirectlyorindirectlyprohibitorrestrict a pharmacist or pharmacy from offering, directly or through a third party, services or products to increase transparency, access, and affordability of prescriptiondrugs forpatients.
Such servicesand products include butarenot limited to:
(a) Simplified payment processes, electronic payments, or payment plans.
(b) Adherence support services or communications.
(c) Information regarding patient out-of-pocket costs or alternative medication options.
(d) Electronic transactions that allow the pharmacist or pharmacy to provide patients with price and benefits transparency.
(e) Sharing claims data or other healthcare transaction data of patients with thepatient,thepatient's healthcareproviders,abusiness associate as that termis definedin45CFR160.103,orany third partyauthorizedby thepatient at the time the pharmacist or pharmacy runs the claim or other electronic transaction or at any time thereafter.
(f) Electronic transactions that allow the pharmacist or pharmacy to provide patients with prior authorization support to enable access to the patient's prescription drug.
(g) Any lawful copayment assistance or other out-of-pocket support to patients to lower the costs of their prescription drugs.
(2)Apharmacybenefitmanager,oranyaffiliate,subsidiary,oragentof a pharmacy benefit manager, shall not directly or indirectly:
Page 13 of 19 Coding:
Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.
SB NO.
387 ENROLLED (a) Audit, investigate, terminate, or threaten to terminate a pharmacist or pharmacy from the pharmacy benefit manager's network as a result of the pharmacist or pharmacy engaging in any activity described in or allowed by Paragraph (1) of this Subsection.
(b)Reduce,rescind,orotherwiseclawbackanyreimbursementpayment in whole or in part to a pharmacist or pharmacy for a prescriptions drug's ingredient cost or dispensing fee as a result of the pharmacist or pharmacy engaging in any activity described in or allowed by Paragraph (1) of this Subsection.
(c) Discriminate against or otherwise penalize a pharmacist or pharmacy, including but not limited to decreasing any reimbursementratesor by reclassifying the pharmacist or pharmacy's class of trade as a result of the pharmacist or pharmacy engaging in any activity described in or allowed by Paragraph (1) of this Subsection.
(3) Nothing in this Subsection shall be construed to modify or limit the application of R.S.
40:2870(A)(3)to a pharmacy benefit manager'shandling of beneficiarypersonalhealthcareorcontactinformation.Apharmacy'ssharing ofclaimsdataorotherhealthcaretransactiondatawithabusiness associate,as that term is defined in 45 CFR 160.103, in compliance with the Health Insurance Portability and Accountability Act of 1996 and its implementing regulations, shall not constitute a pharmacy benefit manager buying, selling, transferring, or providing personal health care or contact information within the meaning of R.S.
40:2870(A)(3).
(4) Any contract provision between a pharmacy benefit manager and a pharmacist or pharmacy that conflicts with this Subsection shall be severable from the contract and considered void and unenforceable in this state.
(5) A violation of this Subsection is subject to the penalties provided in this Section.
Pharmacy benefit manager formularies A.Page 14 of 19 Coding:
Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.
SB NO.
387 ENROLLED A.
(a)Has an investmentorownershipinvestment orownership interestgreaterthan fivepercentin a pharmacy benefit manager.
(3) "Biosimilar" has the same meaning as in the Public Health Service PageAct, 1342 ofU.S.C. 18 Coding:
Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.
SLS 26RS-518 REENGROSSED SB NO.
387 Act, 42 U.S.C.
B.(1) A pharmacy benefit manager revising the formulary of covered prescription drugs at the beginning of a plan year shall provide a sixtysixty-day day continuity-of-care period in which the covered prescription drug that is being revisedrevisedfromtheformularycontinuestobeprovidedinthesameformularytier fromand thecost-sharing formularystructure continues to be provided at the same cost for the insured for a period of sixty days.
(2)Thesixtydaycontinuity-of-careperiodcommencesuponnotification(2)Thesixty-daycontinuity-of-careperiodcommencesuponnotification to the insured by the insurer.
(c)Page The15 prescriptionof drug19 isCoding: subject to an involuntary recall by state or federal authorities and is no longer available on the commercial market.
Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.
SB NO.
387 ENROLLED (c) The prescription drug is subject to an involuntary recall by state or federal authorities and is no longer available on the commercial market.
E.Otherthanatthetimeofcoveragerenewal,whileaninsuredistaking Pagea 14prescription drug a pharmacy benefit manager shall not do any of 18the Coding:following:
Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.
SLS 26RS-518 REENGROSSED SB NO.
387 a prescription drug a pharmacy benefit manager shall not do any of the following:
(c)The drug has beenbeenapproved approvedandmadeavailableoverthecounterby and madeavailableoverthecounterby the United States Food and Drug Administration and entered the commercial market as such.
F.ThisSectiondoesnotprohibittheadditionofprescriptiondrugstothePage formulary16 duringof the19 policyCoding: year.
Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.
SB NO.
387 ENROLLED F.ThisSectiondoesnotprohibittheadditionofprescriptiondrugstothe formulary during the policy year.
The provisions of this SectionSubpart shall not apply only to healththe benefitextent plansnot thatpreempted areor establishedotherwise underprohibited and regulated by thefederal Employeelaw. Retirement Income Security Act (ERISA) of 1974.
To the extent such conflict exists,thevalidityoftheremainderofthisSubpartandtheapplicabilitythereof to any other entity, person, or circumstance shall not be affected.
44:4.1(B)(11)39:1600.1(A), isthe herebyintroductory amendedparagraph of 1600.1(D), and 1600.1(D)(6) are herebyamended and reenacted to read as follows:
§4.1.§1600.1.
ExceptionsProcurement *of *pharmacybenefit *manager B.Thelegislaturefurtherrecognizesthatthereexistexceptions,exemptions,services andby limitationsreverse toauction theA.(1) lawsThis pertainingsection toshall publicbe recordsknown throughoutand themay revisedbe statutesandcodesofthisstate.Therefore,thefollowingexceptions,exemptions,andcited Pageas 15the of"Louisiana 18Competitive Coding:Pharmacy Benefit Managers Act".
(2)ItisrecommendedtoconducttheinitialPBMreverseauctionnolater thanJuly1,2028.Termsofanycontractforpharmacybenefitservicesawarded through the initial reverse auction process may become effective at commencement of the new plan year beginning January 1, 2029.
(3) It is recommended that PBM reverse auctions be conducted in accordance with the provisions of this Chapter at a frequency of no less than once every five years.
* * * D.
Contracts It is recommended that contracts for pharmacy benefit managerservicesobtainedthroughreverseauctionshall complywith thefollowing:
* * * (6)(a) With technical assistance and support provided by the technology platform provider, the division of administration shall specify the terms of the participantbiddingagreementwhichshallnotbemodifiedexceptbyspecificconsent of the division of administration.
(b) It is recommended that the participant bidding agreement require qualified bidders in the PBM reverse auction process, both full service PBMs and carve-out service providers, to comply with the terms and provisions of all PBM regulations in Title 22 of the Louisiana Revised Statutes of 1950.
Page 17 of 19 Coding:
SLS 26RS-518 REENGROSSED SB NO.
387 limitationsENROLLED are(c) herebyIt continuedis inrecommended effectthat byqualified incorporationspecialty intocarve-out thisprescription ChapterdrugserviceproviderscompetewithfullservicePBMsonthebasisofpriceand byany citation:other appropriate criteria for award of a specialty drug contract over multiple rounds of dynamically competitive reverse auction bidding.
(d)Itisrecommendedthatqualifiedgenericcarve-outprescriptiondrug service providers compete with full service PBMs on the basis of price and any other appropriate criteria for award of a generic drug contract over multiple rounds of dynamically competitive reverse auction bidding.
(e)The PBMreverseauction processmayresultin award of multiple or hybrid contracts to full service and carve-out prescription service providers if such award is determined to be of higher value to the state.
* * * Section 3.
R.S.
44:4.1(B)(11) is hereby amended and reenacted to read as follows:
§4.1.
Exceptions * * * B.Thelegislaturefurtherrecognizesthatthereexistexceptions,exemptions, and limitations to the laws pertaining to public records throughout the revised statutesandcodesofthisstate.Therefore,thefollowingexceptions,exemptions,and limitations are hereby continued in effect by incorporation into this Chapter by citation:
22:2, 14, 31, 42.1, 88, 244, 263, 265, 461, 550.7, 550.22, 550.29, 550.30, 571, 572, 572.1, 572.2, 574, 601.3, 618, 639, 691.4, 691.5, 691.6, 691.7, 691.8,691.9,691.9.1,691.10,691.38,691.56,732,752,753,771,834,972(D),976, 1008, 1019.2, 1203, 1460, 1464, 1466, 1483.1, 1488, 1546, 1559, 1566(D), 1644, 1656, 1657.1, 1660.7, 1723, 1796, 1801, 1808.3, 1867.1, 1869, 1927, 1929, 1983, 1984, 2036, 2045, 2056, 2085, 2091, 2293, 2303, 2508 * * * Section 3.4.
22:1868.1 isand Section 5 of Act 474 of the 2025 Regular Session are hereby repealed.repealed in their entirety.
Section4.ThisActshalltakeeffectandbecomeoperativeifandwhentheActwhichPage originated18 asof Senate19 BillCoding: No.
401 of this 2026 Regular Session of the Legislature is enacted and becomes effective.
If vetoed by the governor and subsequently approved by the legislature, this Act shall become effective on the date that Senate Bill No.
401 becomes effective.
The original instrument and the following digest, which constitutes no part of the legislative instrument, were prepared bySenate Legislative Services.
The keyword, summary, and digest do not constitute part of the law or proof or indicia of legislative intent.
[R.S.
1:13(B) and 24:177(E)] DIGEST SB 387 Reengrossed 2026 Regular Session Bass Present law provides for definitions.
Proposed law retains present law and adds definitions for "enrollee", "healthcare service", "person", "pharmacy benefit management fee", "pharmacy benefit management service", "provider", and "related entity".
Proposed law also amends the definition for "rebates".
Proposed law provides for a PBM's fiduciarydutyof care and good faith and fair dealing to enrollees.
ProposedlawprovidesforPBMcompensationthroughpharmacybenefitmanagerflatdollar feesandflatdollarperformancebonus andprohibits aPBMfromretainingrebatesandfees.
Proposedlawallowsthecommissionerofinsuranceandanyhealthinsuranceissuerorhealth plan contracted with a PBM to audit the PBM once per calendar year.
Proposed law further provides for information that may be requested as part of the audit and provides for the protection of confidential and proprietaryinformation through a public records exemption, including the books and records from anyentity in the PBM's vertical corporate structure.
Page 16 of 18 Coding:
SLS 26RS-518 REENGROSSED SB NO.
387 ProposedlawrequiresPBMcontractstospecifyallformsofrevenuetobepaidbythehealthENROLLED insuranceSection issuer5. or health plan to the pharmacy benefit manager and to acknowledge that spread pricing is not permitted.
ProposedSections law1 providesthrough that,4 inand addition6 tothrough anyother8 civilof orthis criminalAct penaltyshall authorizedtake byeffect law,aviolationofproposedlawispunishablebythecommissionerthroughacivilmonetaryand penaltyof$25,000foreachandeveryactorviolation,become withenforceable noaggregatepenaltymaximum.only if Section 4 of the Act which originated as Senate Bill No.
Proposed401 lawof furtherthe provides2026 thatRegular ifSession a violation is not corrected within 30 days after notice of the violationLegislature is receivedenacted byand thebecomes PBM,effective. the commissioner must suspend or revoke the pharmacy benefit manager's license.
ProposedSection law6. is to be implemented to regulate a pharmacy benefit manager or health insurance issuer only to the extent permissible under applicable law.
PresentThe lawprovisions allowsof athis PBMAct toamending auditand pharmacyreenacting claims.R.S.
Proposed22:1856.1 lawand limits1865 toand enacting 1867.1(C) and 1867.1(E) and (F), shall become effective upon signature of the auditgovernor toor, claimsif filednot withinsigned by the 12governor, monthsupon priorexpiration toof the starttime for bills to become law without signature bythe governor, as provided byArticle III, Section 18 of the audit.Constitution of Louisiana.
ProposedIf lawvetoed allowsby athe pharmacytogovernor submitand asubsequently consolidatedapproved appealby tothe alegislature, PBMthese provisions of substantiallythis similarAct claims.shall become effective on the day following such approval.
ProposedlawprohibitsaPBMfromusingitsformularytoobtaininducements,favorcertainSection drugs7. over substantially similar drugs with a lower cost, charge more that the PBM's net acquisition cost of a drug, or ban the use of certain pharmacies byan insured.
ProposedThe lawprovisions provides for a 60-day continuity of carethis forAct anamending enrollee when a formulary is changed and removesreenacting aR.S. drug prescribed to an enrollee.
Proposed22:1863 lawand providesenacting that1867.1(A)(1), proposed(2), lawand is(4) notand applicable(D) toshall ERISAbecome plans.effective on January 1, 2027.
EffectiveSection8.TheprovisionsofthisActamendingandreenactingR.S.39:1600.1(A)and the introductory paragraph of 1600.1(D) and 1600.1(D)(6) and enacting 1867.1(A)(3) and (B) and 1868.2 shall become effective on January 1, 2027.2028.
(AmendsPRESIDENT R.S.OF THE SENATE SPEAKER OF THE HOUSE OF REPRESENTATIVES GOVERNOR OF THE STATE OF LOUISIANA APPROVED:
22:1856.1(B)(2)(a),Page 1863,19 1865(A),of and19 R.S.Coding:
44:4.1(B)(11);
adds R.S.
22:1867.1 and 1868.2;
repeals R.S.22:1868.1) Summary of Amendments Adopted by Senate CommitteeAmendmentsProposedbySenateCommitteeonInsurancetotheoriginal bill 1.
Limits a PBM pharmacyaudit to claims submitted not more than 12 months prior to the audit.
2.
Allows for consolidated appeals.
3.
Provides that a PBM owes a fiduciary duty to enrollees, pharmacies, and plans.
4.
Prohibits a PBM from obtaining an inducement on a name brand drug in exchange for not placing other drugs of the same class on the PBM formulary.
5.
Prohibits a PBM from favoring certain drugs over others on a formulary.
6.
Prohibits a PBM from charging a cost greater than net acquisition cost.
7.
Prohibits a PBM from using its formulary to ban the use of certain pharmacies.
Page 17 of 18 Coding:
Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.
SLS 26RS-518 REENGROSSED SB NO.
387 8.
Prohibits a PBM or GPO from retaining rebates and fees, requiring them to be passed through to the plan.
9.
Allows a PBM to earn income only from a flat dollar fee.
10.
Allows a PBM to receive a flat dollar performance bonus.
11.
Allows the commissioner of insurance to examine the books or records of any entity in a PBM's corporate structure.
12.
Requires continuityof carefor enrollees when a PBM formularyis changed.
13.
Provides that proposed law becomes effective if SB 401 is enacted.
14.
Makes technical changes.
Senate Floor Amendments to engrossed bill 1.
Provides that PBMs do not owe a fiduciary duty to plans or pharmacies.
2.
Provides that the provisions of proposed law are not applicable to ERISA plans.
3.
Makes technical changes.
Page 18 of 18 Coding:
Show all 272 changed rows (232 more)
View plain text versions (6)
- Enrolled SB387 Enrolled Current pdf
- Engrossed SB387 Reengrossed pdf
- Engrossed SB387 Engrossed pdf
- SB387 Act 914 View text pdf
- SB387 Original View text pdf
- Conference Committee Report, #4456, House Proposed, Senate Adopted View text pdf
Amendments
7 amendments- House Committee Amendment, #4796, INS, Adopted Adopted Show changes
- House Committee Amendment, #4624, INS, Draft Show changes
- Senate Floor Amendment, #2066, Bass, Adopted Adopted Show changes
- Senate Floor Amendment, #1861, Bass, Adopted Adopted Show changes
- Senate Floor Amendment, #1858, Bass, Adopted Adopted Show changes
- Senate Committee Amendment, #1640, INS, Adopted Adopted Show changes
- Senate Committee Amendment, #1440, INS, Draft Show changes
Click Show changes on an amendment above to see how it modifies the bill.
Action History
-
Signed by the Governor. Becomes Act No. 914.
-
Effective date: See Act.
-
Enrolled. Signed by the President of the Senate.
-
Signed by the Speaker of the House.
-
Sent to the Governor by the Secretary of the Senate on 6/2/2026.
-
Conference Committee Report read, roll called, yeas 76, nays 13. The Conference Committee Report was adopted.
-
Notice House adopted the Conference Committee Report.
-
Conference committee report received.
-
Rules suspended.
-
Conference Committee Report read; adopted by a vote of 36 yeas and 0 nays.
-
Conference Committee report received. Lies over under the rules.
-
Notice of Senate adoption of Conference Committee Report.
-
Scheduled for floor debate on 05/31/2026.
-
Senate conference committee members appointed: Talbot, Bass, and Harris.
-
Notice of Senate conferees appointed.
-
Notice of Senate rejecting House amendments.
-
House conferees appointed: Turner, Firment, and Miller.
-
Notice House Conference Committee members appointed.
-
Amendments proposed by the House read and rejected by a vote of 34 yeas and 0 nays.
-
Read third time by title, roll called on final passage, yeas 82, nays 14. Finally passed, ordered to the Senate.
-
Received from the House with amendments.
-
Read by title, passed to 3rd reading.
-
Scheduled for floor debate on 05/19/2026.
-
Reported without Legislative Bureau amendments.
-
Reported favorably (12-0). Referred to the Legislative Bureau.
-
Read by title, amended, recommitted to the Committee on House and Governmental Affairs.
-
Reported with amendments (10-4). To be recommitted to the Committee on House and Governmental Affairs.
-
Read by title, under the rules, referred to the Committee on Insurance.
-
Received in the House from the Senate, read by title, lies over under the rules.
-
Called from the Calendar.
-
Senate floor amendments read and adopted. Read by title and passed by a vote of 37 yeas and 0 nays; ordered reengrossed and sent to the House. Motion to reconsider tabled.
-
Senate floor amendments read and adopted.
-
Read by title and returned to the Calendar, subject to call.
-
Read by title. Committee amendments read and adopted. Ordered engrossed and passed to third reading and final passage.
-
Reported with amendments.
-
Introduced in the Senate; read by title. Rules suspended. Read second time and referred to the Committee on Insurance.
-
Prefiled and under the rules provisionally referred to the Committee on Insurance.
Sponsors
- Christopher Turner · Cosponsor
- Kirk Talbot · Cosponsor
- Adam Bass · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 2 co-sponsors · 144 not signed on · 20 voted No
Sponsors (1)
- Adam Bass Republican
Co-sponsors (2)
- Christopher Turner Republican
- Kirk Talbot Republican
Not signed on (144)
144 members have not signed on to this bill.
Show all 144 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Votes
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Unaffiliated | 5 | 1 | 0 | 1 |
| Republican | 60 | 0 | 0 | 8 |
| Democrat | 11 | 12 | 0 | 7 |
| Total | 76 | 13 | 0 | 16 |
| % of votes cast | 72% | 12% | 0% | 15% |
How each member voted (105)
| Member | Party | Vote |
|---|---|---|
| Mr. Speaker | — | Yea |
| Amedee | — | Yea |
| Stagni | — | Yea |
| Galle | — | Not Voting |
| Johnson, T. | — | Yea |
| Landry, T. | — | Nay |
| St. Blanc | — | Yea |
| Adrian Fisher | Democrat | Nay |
| Aimee Adatto Freeman | Democrat | Nay |
| Alonzo L. Knox | Democrat | Not Voting |
| Barbara Carpenter | Democrat | Yea |
| C. Denise Marcelle | Democrat | Nay |
| Candace N. Newell | Democrat | Nay |
| Chasity Martinez | Democrat | Yea |
| Dana Henry | Democrat | Yea |
| Delisha Boyd | Democrat | Yea |
| Ed Murray | Democrat | Nay |
| Edmond Jordan | Democrat | Yea |
| Gerald Boudreaux | Democrat | Yea |
| III, Ed Larvadain | Democrat | Nay |
| Joy Walters | Democrat | Not Voting |
| Jr., Kyle M. Green | Democrat | Yea |
| Ken Brass | Democrat | Not Voting |
| Mandie Landry | Democrat | Nay |
| Marcus Anthony Bryant | Democrat | Yea |
| Pat Moore | Democrat | Nay |
| Rashid Armand Young | Democrat | Not Voting |
| Robby Carter | Democrat | Nay |
| Rodney Lyons | Democrat | Yea |
| Roy Daryl Adams | Democrat | Yea |
| Shaun Raphael Mena | Democrat | Nay |
| Sr., Wilford Carter | Democrat | Not Voting |
| Steven Jackson | Democrat | Nay |
| Sylvia Elaine Taylor | Democrat | Nay |
| Tammy T. Phelps | Democrat | Not Voting |
| Tehmi Jahi Chassion | Democrat | Not Voting |
| Vanessa Caston LaFleur | Democrat | Yea |
| Annie Spell | Republican | Yea |
| Barbara Reich Freiberg | Republican | Yea |
| Beth Anne Billings | Republican | Yea |
| Brett F. Geymann | Republican | Not Voting |
| Brian Leonard Glorioso | Republican | Yea |
| Bryan Fontenot | Republican | Yea |
| Chad Michael Boyer | Republican | Yea |
| Chance Keith Henry | Republican | Yea |
| Christopher Turner | Republican | Yea |
| Danny McCormick | Republican | Yea |
| Daryl Andrew Deshotel | Republican | Yea |
| Debbie Villio | Republican | Yea |
| Dixon Wallace McMakin | Republican | Yea |
| Dodie Horton | Republican | Yea |
| Emily Chenevert | Republican | Yea |
| Foy Bryan Gadberry | Republican | Yea |
| Francis C. Thompson | Republican | Yea |
| Gregory A. Miller | Republican | Yea |
| III, Roger William Wilder | Republican | Yea |
| III, Vincent E. Cox | Republican | Yea |
| IV, Gerald "Beau" Beaullieu | Republican | Yea |
| Jack McFarland | Republican | Yea |
| Jacob Braud | Republican | Yea |
| Jacob Jules Landry | Republican | Yea |
| Jason Brian DeWitt | Republican | Yea |
| Jeffrey "Jeff" Fons Wiley | Republican | Yea |
| Jeremy LaCombe | Republican | Yea |
| Jerome Zeringue | Republican | Yea |
| Jessica Domangue | Republican | Yea |
| John E. Wyble | Republican | Yea |
| Joseph A. Orgeron | Republican | Yea |
| Josh Carlson | Republican | Yea |
| Jr., Dennis Bamburg | Republican | Yea |
| Jr., John R. Illg | Republican | Yea |
| Jr., Michael Robert Bayham | Republican | Not Voting |
| Kathy Edmonston | Republican | Yea |
| Kellee Hennessy Dickerson | Republican | Yea |
| Kim Carver | Republican | Yea |
| Kimberly Landry Coates | Republican | Yea |
| Larry A. Bagley | Republican | Not Voting |
| Lauren Ventrella | Republican | Yea |
| Laurie Schlegel | Republican | Yea |
| Les Farnum | Republican | Not Voting |
| Mark Wright | Republican | Not Voting |
| Michael "Gabe" Firment | Republican | Yea |
| Michael Charles Echols | Republican | Yea |
| Michael Melerine | Republican | Yea |
| Mike Johnson | Republican | Yea |
| Neil Riser | Republican | Yea |
| Nicholas Muscarello | Republican | Yea |
| Paul Sawyer | Republican | Yea |
| Phillip Eric Tarver | Republican | Not Voting |
| Polly Thomas | Republican | Yea |
| R. Dewith Carrier | Republican | Yea |
| Raymond J. Crews | Republican | Yea |
| Reese "Skip" Broussard | Republican | Yea |
| Rhonda Gaye Butler | Republican | Yea |
| Robert "Bob" Owen | Republican | Yea |
| Rodney Schamerhorn | Republican | Yea |
| Ryan Bourriaque | Republican | Yea |
| Shane Mack | Republican | Yea |
| Sr., Peter F. Egan | Republican | Yea |
| Stephanie H. Berault | Republican | Yea |
| Stephanie Hilferty | Republican | Not Voting |
| Timothy P. Kerner | Republican | Yea |
| Tony Bacala | Republican | Not Voting |
| Troy Jude Hebert | Republican | Yea |
| Wayne McMahen | Republican | Yea |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Unaffiliated | 1 | 0 | 0 | 0 |
| Republican | 25 | 0 | 0 | 2 |
| Democrat | 10 | 0 | 0 | 1 |
| Total | 36 | 0 | 0 | 3 |
| % of votes cast | 92% | 0% | 0% | 8% |
How each member voted (39)
| Member | Party | Vote |
|---|---|---|
| Mr. President | — | Yea |
| Edward J. Price | Democrat | Yea |
| Gary Carter | Democrat | Yea |
| Gerald Boudreaux | Democrat | Yea |
| Jay Luneau | Democrat | Yea |
| Jimmy Harris | Democrat | Yea |
| Katrina R. Jackson-Andrews | Democrat | Yea |
| Larry Selders | Democrat | Not Voting |
| Regina Barrow | Democrat | Yea |
| Royce Duplessis | Democrat | Yea |
| Sam Jenkins | Democrat | Yea |
| Sidney Barthelemy II | Democrat | Yea |
| Adam Bass | Republican | Yea |
| Alan Seabaugh | Republican | Yea |
| Beth Mizell | Republican | Yea |
| Blake Miguez | Republican | Yea |
| Bob Hensgens | Republican | Yea |
| Brach Jerad Myers | Republican | Yea |
| Caleb Kleinpeter | Republican | Yea |
| Eddie J. Lambert | Republican | Yea |
| Franklin J. Foil | Republican | Yea |
| Glen Womack | Republican | Not Voting |
| Gregory A. Miller | Republican | Yea |
| Heather Cloud | Republican | Not Voting |
| Jeremy Stine | Republican | Yea |
| John C. "Jay" Morris | Republican | Yea |
| Jr., William "Bill" Wheat | Republican | Yea |
| Kirk Talbot | Republican | Yea |
| Mark Abraham | Republican | Yea |
| Michael "Big Mike" Fesi | Republican | Yea |
| Mike Reese | Republican | Yea |
| Patrick Connick | Republican | Yea |
| Patrick McMath | Republican | Yea |
| Rick Edmonds | Republican | Yea |
| Robert "Bob" Owen | Republican | Yea |
| Robert Allain | Republican | Yea |
| Stewart Jr. Cathey | Republican | Yea |
| Thomas A. Pressly | Republican | Yea |
| Valarie Hodges | Republican | Yea |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Unaffiliated | 1 | 0 | 0 | 0 |
| Republican | 26 | 0 | 0 | 1 |
| Democrat | 7 | 0 | 0 | 4 |
| Total | 34 | 0 | 0 | 5 |
| % of votes cast | 87% | 0% | 0% | 13% |
How each member voted (39)
| Member | Party | Vote |
|---|---|---|
| Mr. President | — | Yea |
| Edward J. Price | Democrat | Yea |
| Gary Carter | Democrat | Yea |
| Gerald Boudreaux | Democrat | Yea |
| Jay Luneau | Democrat | Yea |
| Jimmy Harris | Democrat | Yea |
| Katrina R. Jackson-Andrews | Democrat | Not Voting |
| Larry Selders | Democrat | Not Voting |
| Regina Barrow | Democrat | Not Voting |
| Royce Duplessis | Democrat | Not Voting |
| Sam Jenkins | Democrat | Yea |
| Sidney Barthelemy II | Democrat | Yea |
| Adam Bass | Republican | Yea |
| Alan Seabaugh | Republican | Yea |
| Beth Mizell | Republican | Yea |
| Blake Miguez | Republican | Yea |
| Bob Hensgens | Republican | Yea |
| Brach Jerad Myers | Republican | Not Voting |
| Caleb Kleinpeter | Republican | Yea |
| Eddie J. Lambert | Republican | Yea |
| Franklin J. Foil | Republican | Yea |
| Glen Womack | Republican | Yea |
| Gregory A. Miller | Republican | Yea |
| Heather Cloud | Republican | Yea |
| Jeremy Stine | Republican | Yea |
| John C. "Jay" Morris | Republican | Yea |
| Jr., William "Bill" Wheat | Republican | Yea |
| Kirk Talbot | Republican | Yea |
| Mark Abraham | Republican | Yea |
| Michael "Big Mike" Fesi | Republican | Yea |
| Mike Reese | Republican | Yea |
| Patrick Connick | Republican | Yea |
| Patrick McMath | Republican | Yea |
| Rick Edmonds | Republican | Yea |
| Robert "Bob" Owen | Republican | Yea |
| Robert Allain | Republican | Yea |
| Stewart Jr. Cathey | Republican | Yea |
| Thomas A. Pressly | Republican | Yea |
| Valarie Hodges | Republican | Yea |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Unaffiliated | 6 | 0 | 0 | 1 |
| Republican | 63 | 1 | 0 | 4 |
| Democrat | 13 | 13 | 0 | 4 |
| Total | 82 | 14 | 0 | 9 |
| % of votes cast | 78% | 13% | 0% | 9% |
How each member voted (105)
| Member | Party | Vote |
|---|---|---|
| Mr. Speaker | — | Yea |
| Amedee | — | Yea |
| Galle | — | Yea |
| Stagni | — | Yea |
| Johnson, T. | — | Not Voting |
| Landry, T. | — | Yea |
| St. Blanc | — | Yea |
| Adrian Fisher | Democrat | Yea |
| Aimee Adatto Freeman | Democrat | Nay |
| Alonzo L. Knox | Democrat | Not Voting |
| Barbara Carpenter | Democrat | Yea |
| C. Denise Marcelle | Democrat | Nay |
| Candace N. Newell | Democrat | Nay |
| Chasity Martinez | Democrat | Nay |
| Dana Henry | Democrat | Yea |
| Delisha Boyd | Democrat | Nay |
| Ed Murray | Democrat | Nay |
| Edmond Jordan | Democrat | Nay |
| Gerald Boudreaux | Democrat | Yea |
| III, Ed Larvadain | Democrat | Yea |
| Joy Walters | Democrat | Nay |
| Jr., Kyle M. Green | Democrat | Nay |
| Ken Brass | Democrat | Yea |
| Mandie Landry | Democrat | Nay |
| Marcus Anthony Bryant | Democrat | Nay |
| Pat Moore | Democrat | Yea |
| Rashid Armand Young | Democrat | Not Voting |
| Robby Carter | Democrat | Yea |
| Rodney Lyons | Democrat | Yea |
| Roy Daryl Adams | Democrat | Yea |
| Shaun Raphael Mena | Democrat | Nay |
| Sr., Wilford Carter | Democrat | Yea |
| Steven Jackson | Democrat | Nay |
| Sylvia Elaine Taylor | Democrat | Yea |
| Tammy T. Phelps | Democrat | Not Voting |
| Tehmi Jahi Chassion | Democrat | Not Voting |
| Vanessa Caston LaFleur | Democrat | Yea |
| Annie Spell | Republican | Yea |
| Barbara Reich Freiberg | Republican | Yea |
| Beth Anne Billings | Republican | Yea |
| Brett F. Geymann | Republican | Yea |
| Brian Leonard Glorioso | Republican | Yea |
| Bryan Fontenot | Republican | Yea |
| Chad Michael Boyer | Republican | Yea |
| Chance Keith Henry | Republican | Yea |
| Christopher Turner | Republican | Yea |
| Danny McCormick | Republican | Yea |
| Daryl Andrew Deshotel | Republican | Yea |
| Debbie Villio | Republican | Yea |
| Dixon Wallace McMakin | Republican | Not Voting |
| Dodie Horton | Republican | Yea |
| Emily Chenevert | Republican | Yea |
| Foy Bryan Gadberry | Republican | Yea |
| Francis C. Thompson | Republican | Not Voting |
| Gregory A. Miller | Republican | Nay |
| III, Roger William Wilder | Republican | Yea |
| III, Vincent E. Cox | Republican | Yea |
| IV, Gerald "Beau" Beaullieu | Republican | Yea |
| Jack McFarland | Republican | Yea |
| Jacob Braud | Republican | Yea |
| Jacob Jules Landry | Republican | Yea |
| Jason Brian DeWitt | Republican | Yea |
| Jeffrey "Jeff" Fons Wiley | Republican | Yea |
| Jeremy LaCombe | Republican | Yea |
| Jerome Zeringue | Republican | Yea |
| Jessica Domangue | Republican | Yea |
| John E. Wyble | Republican | Yea |
| Joseph A. Orgeron | Republican | Yea |
| Josh Carlson | Republican | Yea |
| Jr., Dennis Bamburg | Republican | Yea |
| Jr., John R. Illg | Republican | Yea |
| Jr., Michael Robert Bayham | Republican | Yea |
| Kathy Edmonston | Republican | Yea |
| Kellee Hennessy Dickerson | Republican | Yea |
| Kim Carver | Republican | Yea |
| Kimberly Landry Coates | Republican | Yea |
| Larry A. Bagley | Republican | Not Voting |
| Lauren Ventrella | Republican | Yea |
| Laurie Schlegel | Republican | Yea |
| Les Farnum | Republican | Yea |
| Mark Wright | Republican | Yea |
| Michael "Gabe" Firment | Republican | Yea |
| Michael Charles Echols | Republican | Yea |
| Michael Melerine | Republican | Yea |
| Mike Johnson | Republican | Yea |
| Neil Riser | Republican | Yea |
| Nicholas Muscarello | Republican | Yea |
| Paul Sawyer | Republican | Yea |
| Phillip Eric Tarver | Republican | Yea |
| Polly Thomas | Republican | Yea |
| R. Dewith Carrier | Republican | Yea |
| Raymond J. Crews | Republican | Yea |
| Reese "Skip" Broussard | Republican | Yea |
| Rhonda Gaye Butler | Republican | Yea |
| Robert "Bob" Owen | Republican | Yea |
| Rodney Schamerhorn | Republican | Yea |
| Ryan Bourriaque | Republican | Yea |
| Shane Mack | Republican | Yea |
| Sr., Peter F. Egan | Republican | Yea |
| Stephanie H. Berault | Republican | Yea |
| Stephanie Hilferty | Republican | Not Voting |
| Timothy P. Kerner | Republican | Yea |
| Tony Bacala | Republican | Yea |
| Troy Jude Hebert | Republican | Yea |
| Wayne McMahen | Republican | Yea |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Unaffiliated | 1 | 0 | 0 | 0 |
| Republican | 26 | 0 | 0 | 1 |
| Democrat | 10 | 0 | 0 | 1 |
| Total | 37 | 0 | 0 | 2 |
| % of votes cast | 95% | 0% | 0% | 5% |
How each member voted (39)
| Member | Party | Vote |
|---|---|---|
| Mr. President | — | Yea |
| Edward J. Price | Democrat | Yea |
| Gary Carter | Democrat | Yea |
| Gerald Boudreaux | Democrat | Yea |
| Jay Luneau | Democrat | Yea |
| Jimmy Harris | Democrat | Yea |
| Katrina R. Jackson-Andrews | Democrat | Yea |
| Larry Selders | Democrat | Yea |
| Regina Barrow | Democrat | Not Voting |
| Royce Duplessis | Democrat | Yea |
| Sam Jenkins | Democrat | Yea |
| Sidney Barthelemy II | Democrat | Yea |
| Adam Bass | Republican | Yea |
| Alan Seabaugh | Republican | Yea |
| Beth Mizell | Republican | Yea |
| Blake Miguez | Republican | Yea |
| Bob Hensgens | Republican | Yea |
| Brach Jerad Myers | Republican | Yea |
| Caleb Kleinpeter | Republican | Yea |
| Eddie J. Lambert | Republican | Yea |
| Franklin J. Foil | Republican | Yea |
| Glen Womack | Republican | Yea |
| Gregory A. Miller | Republican | Yea |
| Heather Cloud | Republican | Yea |
| Jeremy Stine | Republican | Yea |
| John C. "Jay" Morris | Republican | Yea |
| Jr., William "Bill" Wheat | Republican | Yea |
| Kirk Talbot | Republican | Yea |
| Mark Abraham | Republican | Yea |
| Michael "Big Mike" Fesi | Republican | Yea |
| Mike Reese | Republican | Yea |
| Patrick Connick | Republican | Yea |
| Patrick McMath | Republican | Yea |
| Rick Edmonds | Republican | Yea |
| Robert "Bob" Owen | Republican | Yea |
| Robert Allain | Republican | Yea |
| Stewart Jr. Cathey | Republican | Yea |
| Thomas A. Pressly | Republican | Yea |
| Valarie Hodges | Republican | Not Voting |
Subjects
Frequently asked questions
- Who sponsors SB 387?
- SB 387 is sponsored by Christopher Turner (Republican), Kirk Talbot (Republican), and Adam Bass (Republican).
- What is the current status of SB 387?
- This bill has been enacted into law. Introduced February 27, 2026. Enacted.
- Where can I track SB 387?
- Track SB 387 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 387
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 387
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →